D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
PUT
Bally's
BALY
$686M
| $260K | ﹤0.01% |
15,100
| – | – |
|
3902
iShares Global Infrastructure ETF
IGF
$10.9B
| $260K | ﹤0.01% |
+4,774
| New | +$244K |
|
3903
eGain
EGAN
$187M
| $259K | ﹤0.01% |
50,762
-21,208
| -29% | -$136K |
|
3904
PUT
AMN Healthcare
AMN
$1.3B
| $259K | ﹤0.01% |
6,100
| – | – |
|
|
AKRO
3905
CALL
DELISTED
Akero Therapeutics
AKRO
| $258K | ﹤0.01% |
+9,000
| New | +$235K |
|
3906
iShares Core S&P US Growth ETF
IUSG
$31.1B
| $257K | ﹤0.01% |
+1,949
| New | +$248K |
|
3907
PUT
Galicia Financial Group
GGAL
$8.03B
| $257K | ﹤0.01% |
+6,100
| New | +$212K |
|
3908
ORIX
IX
$43.9B
| $256K | ﹤0.01% |
11,025
-2,195
| -17% | -$51.6K |
|
3909
Mid Penn Bancorp
MPB
$957M
| $256K | ﹤0.01% |
8,567
-6,234
| -42% | -$170K |
|
3910
Nuvation Bio
NUVB
$2.32B
| $255K | ﹤0.01% |
111,227
-60,568
| -35% | -$185K |
|
3911
Great Southern Bancorp
GSBC
$863M
| $254K | ﹤0.01% |
4,431
-925
| -17% | -$53.8K |
|
3912
ThredUp
TDUP
$756M
| $253K | ﹤0.01% |
300,967
-745,234
| -71% | -$911K |
|
|
LUCK
3913
Lucky Strike Entertainment
LUCK
$963M
| $253K | ﹤0.01% |
21,581
+7,345
| +52% | +$89.1K |
|
3914
Allogene Therapeutics
ALLO
$604M
| $253K | ﹤0.01% |
90,325
-149,930
| -62% | -$400K |
|
3915
Intellia Therapeutics
NTLA
$1.49B
| $252K | ﹤0.01% |
+12,280
| New | +$283K |
|
3916
PUT
O-I Glass
OI
$1.41B
| $252K | ﹤0.01% |
+19,200
| New | +$230K |
|
3917
Lantheus
LNTH
$7.03B
| $251K | ﹤0.01% |
2,291
-29,183
| -93% | -$3.03M |
|
3918
First Bancorp
FBP
$4.39B
| $250K | ﹤0.01% |
11,825
-73,451
| -86% | -$1.49M |
|
3919
Johnson Outdoors
JOUT
$494M
| $250K | ﹤0.01% |
6,913
-10,091
| -59% | -$371K |
|
3920
CALL
PagerDuty
PD
$753M
| $247K | ﹤0.01% |
13,300
| – | – |
|
3921
Invesco BuyBack Achievers ETF
PKW
$1.71B
| $245K | ﹤0.01% |
2,140
| – | – |
|
3922
TriCo Bancshares
TCBK
$1.84B
| $245K | ﹤0.01% |
5,735
-17,483
| -75% | -$754K |
|
3923
CALL
Clorox
CLX
$11.8B
| $244K | ﹤0.01% |
1,500
-50,000
| -97% | -$7.41M |
|
3924
Tenaya Therapeutics
TNYA
$167M
| $244K | ﹤0.01% |
+126,497
| New | +$357K |
|
|
LOGC
3925
DELISTED
ContextLogic
LOGC
| $243K | ﹤0.01% |
44,589
+26,758
| +150% | +$148K |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.